YU60199A - Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji - Google Patents
Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapijiInfo
- Publication number
- YU60199A YU60199A YU60199A YU60199A YU60199A YU 60199 A YU60199 A YU 60199A YU 60199 A YU60199 A YU 60199A YU 60199 A YU60199 A YU 60199A YU 60199 A YU60199 A YU 60199A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- organo
- therapy
- preparation
- protective activity
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Ovaj pronalazak opisuje nove farmaceutske preparate korisne za tretman različitih ljudskih i životinjskih oboljenja. Ovi farmaceutski preparati sadrže jedan ili više peptida.[The present invention discloses new pharmaceutical compositions useful for the treatment of various human and animal diseases. These pharmaceutical compositions contain one or more salts of BPC (Body Protection Compounds) fragments of 8-15 amino acids or analogs thereof. The cations of the salts are derived from inorganic or organic bases.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97108384 | 1997-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU60199A true YU60199A (sh) | 2002-09-19 |
| RS49733B RS49733B (sr) | 2008-04-04 |
Family
ID=8226822
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6288028B1 (sh) |
| EP (1) | EP0983300B1 (sh) |
| JP (1) | JP3492381B2 (sh) |
| KR (1) | KR100488038B1 (sh) |
| CN (1) | CN1166683C (sh) |
| AR (1) | AR011478A1 (sh) |
| AT (1) | ATE277948T1 (sh) |
| AU (1) | AU731317B2 (sh) |
| BG (1) | BG64023B1 (sh) |
| BR (1) | BR9809457B1 (sh) |
| CA (1) | CA2290739C (sh) |
| CZ (1) | CZ299423B6 (sh) |
| DE (1) | DE69826653T2 (sh) |
| DK (1) | DK0983300T3 (sh) |
| EA (1) | EA002058B1 (sh) |
| ES (1) | ES2229507T3 (sh) |
| HU (1) | HU227800B1 (sh) |
| ID (1) | ID23184A (sh) |
| IL (2) | IL132884A0 (sh) |
| NO (1) | NO321126B1 (sh) |
| NZ (1) | NZ501323A (sh) |
| PL (1) | PL193790B1 (sh) |
| PT (1) | PT983300E (sh) |
| RS (1) | RS49733B (sh) |
| SK (1) | SK159599A3 (sh) |
| TR (1) | TR199902866T2 (sh) |
| UA (1) | UA61955C2 (sh) |
| WO (1) | WO1998052973A1 (sh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4912875B2 (ja) * | 2004-02-27 | 2012-04-11 | 不二製油株式会社 | 癌転移抑制組成物 |
| US8022216B2 (en) * | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| SI24318A (sl) | 2013-03-13 | 2014-09-30 | Diagen D.O.O. | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji |
| US10350293B2 (en) * | 2016-08-23 | 2019-07-16 | Pharmacotherapia d.o.o. | Compositions and methods for treating symptoms associated with multiple sclerosis |
| EP3474820B1 (en) | 2017-08-24 | 2024-02-07 | Novo Nordisk A/S | Glp-1 compositions and uses thereof |
| TW202140062A (zh) | 2020-02-18 | 2021-11-01 | 丹麥商諾佛 儂迪克股份有限公司 | Ｇｌｐ－１組成物及其用途 |
| US11065298B1 (en) * | 2020-04-24 | 2021-07-20 | Chanda Zaveri | Compositions and methods for treating or preventing viral infections |
| US11833189B1 (en) * | 2023-05-15 | 2023-12-05 | Red Mountain Med Spa, LLC | Sublingual Semaglutide-BPC 157 combination for weight loss |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992004368A1 (en) * | 1990-09-11 | 1992-03-19 | Sikiric Predrag | Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
| ES2114170T3 (es) * | 1992-11-16 | 1998-05-16 | Petek Marijan | Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia. |
-
1998
- 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime
- 1998-05-20 CZ CZ0414299A patent/CZ299423B6/cs not_active IP Right Cessation
- 1998-05-20 TR TR1999/02866T patent/TR199902866T2/xx unknown
- 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/ko not_active IP Right Cessation
- 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime
- 1998-05-20 AT AT98929345T patent/ATE277948T1/de active
- 1998-05-20 JP JP54994898A patent/JP3492381B2/ja not_active Expired - Fee Related
- 1998-05-20 EA EA199901061A patent/EA002058B1/ru not_active IP Right Cessation
- 1998-05-20 IL IL13288498A patent/IL132884A0/xx active IP Right Grant
- 1998-05-20 ES ES98929345T patent/ES2229507T3/es not_active Expired - Lifetime
- 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en active IP Right Grant
- 1998-05-20 ID IDW991444A patent/ID23184A/id unknown
- 1998-05-20 UA UA99127002A patent/UA61955C2/uk unknown
- 1998-05-20 DK DK98929345T patent/DK0983300T3/da active
- 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased
- 1998-05-20 CN CNB988053934A patent/CN1166683C/zh not_active Expired - Fee Related
- 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/pt not_active IP Right Cessation
- 1998-05-20 SK SK1595-99A patent/SK159599A3/sk unknown
- 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation
- 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related
- 1998-05-20 HU HU0002329A patent/HU227800B1/hu not_active IP Right Cessation
- 1998-05-20 RS YUP-601/99A patent/RS49733B/sr unknown
- 1998-05-20 PL PL98336897A patent/PL193790B1/pl unknown
- 1998-05-20 PT PT98929345T patent/PT983300E/pt unknown
- 1998-05-20 DE DE69826653T patent/DE69826653T2/de not_active Expired - Lifetime
- 1998-05-26 AR ARP980102425A patent/AR011478A1/es active IP Right Grant
-
1999
- 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation
- 1999-11-19 NO NO19995692A patent/NO321126B1/no not_active IP Right Cessation
- 1999-11-19 BG BG103905A patent/BG64023B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| MXPA03010402A (es) | Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina. | |
| ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| EP1045636A4 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING THE SAME FOR TREATING FAILURE MYOCARDIAL TISSUES | |
| PT698108E (pt) | Vectores adenovirais de origem animal e utilizacao em terapia genica | |
| BG101118A (en) | Therapeutical compounds | |
| PT910647E (pt) | Variantes hiperactivas da dnase i humana | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| NZ332720A (en) | Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia | |
| MX9703621A (es) | Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples. | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| TR200101633T2 (tr) | Farmasötik bileşim | |
| FI940375A (fi) | Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa | |
| BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| IT1290781B1 (it) | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. | |
| GB2331926A (en) | Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine | |
| MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
| PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
| GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
| HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
| EP0967276A3 (en) | Anti-tumor agent comprising salmosin | |
| DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
| RU95110774A (ru) | Олигонуклеотиды, терапевтические композиции, применение композиций |